We have a Board of Directors with a strong collective track record in biotech research investment.
Managing Director, Nomura Phase4 Ventures
General Partner, TVM Capital
Executive Vice President, Global Drug Development, AstraZeneca R&D
Executive Chairman, Albireo
Chief Operating Officer, Albireo
Managing Director, TPG Growth
Dr Anders Ekblom